174 results on '"Schreiber, Stefan"'
Search Results
2. FixNCut: single-cell genomics through reversible tissue fixation and dissociation
3. Epidemiological data and medical care situation of patients with chronic inflammatory diseases in Germany
4. Amino acid auxotrophies in human gut bacteria are linked to higher microbiome diversity and long-term stability
5. Mirikizumab for ulcerative colitis
6. Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn’s disease
7. Trends in the epidemiology of Clostridioides difficile infection in Germany
8. Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial
9. NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer
10. Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease
11. DNA methyltransferase 3A controls intestinal epithelial barrier function and regeneration in the colon
12. Cohort profile: the Food Chain Plus (FoCus) cohort
13. Atmungstherapie an einem Universitätsklinikum: eine Evaluation des Tätigkeitsprofils
14. Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era
15. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
16. Cross-tissue transcriptome-wide association studies identify susceptibility genes shared between schizophrenia and inflammatory bowel disease
17. Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era
18. Correction: Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections
19. Effect of various weight loss interventions on serum NT-proBNP concentration in severe obese subjects without clinical manifest heart failure
20. Profile of patients with inflammatory bowel disease in conjunction with unmet needs and decision-making for choosing a new biologic therapy: a baseline analysis of the VEDOIBD-Study
21. Analysis of single nucleotide polymorphisms in chronic beryllium disease
22. A genome-wide cross-phenotype meta-analysis of the association of blood pressure with migraine
23. Genome-wide study of a Neolithic Wartberg grave community reveals distinct HLA variation and hunter-gatherer ancestry
24. Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections
25. Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report
26. Questioning the IGF1 receptor’s assigned role in CRC – a case for rehabilitation?
27. Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
28. The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
29. Identifying Crohn’s disease signal from variome analysis
30. Prdx4 limits caspase‐1 activation and restricts inflammasome‐mediated signaling by extracellular vesicles
31. Magnetic bead-assisted endoscopic submucosal dissection: a gravity-based traction method for treating large superficial colorectal tumors
32. Linking pre-existing biorepositories for medical research: the PopGen 2.0 Network
33. Ulcerative Colitis: Shifting Sands
34. Patient views on research use of clinical data without consent: Legal, but also acceptable?
35. Healthcare Providers Underestimate Patients’ Glucocorticoid Use in Crohn’s Disease
36. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis
37. Erratum: A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signaling
38. Whole-exome sequencing identifies rare genetic variations in German families with pulmonary sarcoidosis
39. Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
40. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases
41. Ancient DNA study reveals HLA susceptibility locus for leprosy in medieval Europeans
42. Exposure to the gut microbiota drives distinct methylome and transcriptome changes in intestinal epithelial cells during postnatal development
43. The antibiotic resistome and microbiota landscape of refugees from Syria, Iraq and Afghanistan in Germany
44. Intradural spinal tumors in adults—update on management and outcome
45. Publisher Correction: Identification and characterization of two functional variants in the human longevity gene FOXO3
46. Identification and characterization of two functional variants in the human longevity gene FOXO3
47. Dysfunctional nitric oxide signalling increases risk of myocardial infarction
48. Interpreting whole genome and exome sequencing data of individual gastric cancer samples
49. Post-glacial biogeography of trembling aspen inferred from habitat models and genetic variance in quantitative traits
50. Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.